TruBridge (TBRG) Proxy filing summary

Executive summary

• A proposed acquisition of TruBridge, Inc. by Inventurus Knowledge Solutions, Inc. (IKS Health) is underway, with the transaction expected to close in the third quarter of 2026, pending regulatory and shareholder approvals.

• The merger aims to combine IKS Health's AI-driven platform with TruBridge's expertise to enhance healthcare access, support clinicians, and strengthen financial sustainability for community hospitals.

• Both companies will continue to operate independently until the transaction closes, with a commitment to transparent communication and minimal disruption to ongoing operations.

• Employees are assured of no immediate changes to compensation, benefits, or employment status, and any future changes will be communicated in advance.

• Forward-looking statements highlight potential risks, including regulatory approvals, shareholder votes, and integration challenges.

Voting matters and shareholder proposals

• TruBridge stockholders must approve the proposed transaction, and IKS Health shareholders must approve related financing.

• A proxy statement will be filed and mailed to stockholders, who are urged to review it carefully for details on the transaction and related matters.

Board of directors and corporate governance

• Information about directors and executive officers, including recent changes and compensation arrangements, is available in prior proxy statements and SEC filings.

• Any changes in security holdings by directors or officers will be reflected in SEC filings.